JBCHEPHARMPharmaceuticals
JB Chemicals & Pharmaceuticals Ltd — Cash Flow Statement
₹2064.40
-1.97%
JB Chemicals & Pharmaceuticals Ltd Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Free Cash Flow | 782.14 Cr | 539.24 Cr | -139.33 Cr | -536.65 Cr | — |
| Repayment Of Debt | 0.00 | -179.00 Cr | -87.25 Cr | 0.00 | — |
| Issuance Of Capital Stock | 24.00 Cr | 19.99 Cr | 8.48 Cr | 0.00 | — |
| Capital Expenditure | -120.31 Cr | -261.37 Cr | -764.95 Cr | -706.79 Cr | — |
| End Cash Position | 115.09 Cr | 88.22 Cr | 76.93 Cr | 56.54 Cr | — |
| Beginning Cash Position | 88.22 Cr | 76.93 Cr | 56.54 Cr | 22.47 Cr | — |
| Effect Of Exchange Rate Changes | -76000.00 | -0.02 Cr | 0.03 Cr | 0.00 | — |
| Changes In Cash | 26.88 Cr | 11.30 Cr | 20.36 Cr | 34.07 Cr | — |
| Financing Cash Flow | -579.67 Cr | -385.49 Cr | 356.54 Cr | -138.39 Cr | — |
| Interest Paid Cff | -9.62 Cr | -44.21 Cr | -32.23 Cr | -2.46 Cr | — |
| Cash Dividends Paid | -237.04 Cr | -156.99 Cr | -127.59 Cr | -127.56 Cr | — |
| Common Stock Dividend Paid | -237.04 Cr | -156.99 Cr | -127.59 Cr | -127.56 Cr | — |
| Net Common Stock Issuance | 24.00 Cr | 19.99 Cr | 8.48 Cr | 0.00 | — |
| Common Stock Issuance | 24.00 Cr | 19.99 Cr | 8.48 Cr | 0.00 | — |
| Net Issuance Payments Of Debt | -343.92 Cr | -191.60 Cr | 523.16 Cr | -0.33 Cr | — |
| Net Short Term Debt Issuance | -343.92 Cr | -12.60 Cr | 1.78 Cr | -0.33 Cr | — |
| Net Long Term Debt Issuance | 0.00 | -179.00 Cr | 521.38 Cr | 0.00 | — |
| Long Term Debt Payments | 0.00 | -179.00 Cr | -87.25 Cr | 0.00 | — |
| Investing Cash Flow | -295.90 Cr | -403.83 Cr | -961.79 Cr | 2.32 Cr | — |
| Interest Received Cfi | 4.54 Cr | 4.08 Cr | 2.18 Cr | 0.94 Cr | — |
| Dividends Received Cfi | 52000.00 | 0.00 | 30000.00 | 0.00 | — |
| Net Investment Purchase And Sale | -181.25 Cr | -147.52 Cr | -199.86 Cr | 700.39 Cr | — |
| Sale Of Investment | 1.06K Cr | 721.33 Cr | 557.01 Cr | 1.21K Cr | — |
| Purchase Of Investment | -1.24K Cr | -868.85 Cr | -756.87 Cr | -508.47 Cr | — |
| Net Intangibles Purchase And Sale | -22.72 Cr | -134.50 Cr | -692.38 Cr | -643.92 Cr | — |
| Purchase Of Intangibles | -22.72 Cr | -134.50 Cr | -692.38 Cr | -643.92 Cr | — |
| Net PPE Purchase And Sale | -96.47 Cr | -125.89 Cr | -71.73 Cr | -55.09 Cr | — |
| Sale Of PPE | 1.11 Cr | 0.98 Cr | 0.84 Cr | 7.78 Cr | — |
| Purchase Of PPE | -97.59 Cr | -126.86 Cr | -72.57 Cr | -62.87 Cr | — |
| Operating Cash Flow | 902.45 Cr | 800.61 Cr | 625.61 Cr | 170.14 Cr | — |
| Taxes Refund Paid | -200.67 Cr | -132.49 Cr | -95.48 Cr | -134.61 Cr | — |
| Change In Working Capital | 7.17 Cr | -5.64 Cr | -29.92 Cr | -302.42 Cr | — |
| Change In Payable | 83.42 Cr | 138.00 Cr | 32.35 Cr | 52.93 Cr | — |
| Change In Inventory | -26.44 Cr | -72.03 Cr | -20.52 Cr | -62.51 Cr | — |
| Change In Receivables | -49.80 Cr | -71.60 Cr | -41.75 Cr | -292.84 Cr | — |
| Other Non Cash Items | 5.15 Cr | 38.70 Cr | 31.19 Cr | 1.03 Cr | — |
| Stock Based Compensation | 54.90 Cr | 41.97 Cr | 69.37 Cr | 62.65 Cr | — |
| Provisionand Write Offof Assets | 4.29 Cr | 11.40 Cr | 3.55 Cr | 0.00 | — |
| Depreciation And Amortization | 171.04 Cr | 138.32 Cr | 114.41 Cr | 72.66 Cr | — |
| Depreciation | 171.04 Cr | 138.32 Cr | 114.41 Cr | 72.66 Cr | — |
| Gain Loss On Investment Securities | -32.21 Cr | -32.74 Cr | -6.90 Cr | -35.04 Cr | — |
| Net Foreign Currency Exchange Gain Loss | 5.60 Cr | -10.60 Cr | -15.83 Cr | 3.52 Cr | — |
| Gain Loss On Sale Of PPE | -0.21 Cr | 0.17 Cr | -72000.00 | -2.55 Cr | — |
| Net Income From Continuing Operations | 887.39 Cr | 751.51 Cr | 555.23 Cr | 504.90 Cr | — |
| Issuance Of Debt | — | 0.00 | 608.63 Cr | 0.00 | 0.32 Cr |
| Long Term Debt Issuance | — | 0.00 | 608.63 Cr | 0.00 | — |
| Net Other Financing Charges | — | — | -5.58 Cr | — | — |
| Net Business Purchase And Sale | — | — | — | 0.00 | -8.50 Cr |
| Purchase Of Business | — | — | — | 0.00 | -8.50 Cr |
| Sale Of Intangibles | — | — | — | 0.00 | 21.57 Cr |
| Pension And Employee Benefit Expense | — | — | — | 0.10 Cr | -16.70 Cr |
| Repurchase Of Capital Stock | — | — | — | — | 0.00 |
| Other Cash Adjustment Outside Changein Cash | — | — | — | — | -1000.00 |
| Common Stock Payments | — | — | — | — | 0.00 |
| Short Term Debt Issuance | — | — | — | — | 0.32 Cr |
| Net Other Investing Changes | — | — | — | — | -0.23 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on JB Chemicals & Pharmaceuticals Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.